Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Philippe Ohlmann"'
Autor:
Sébastien Hess, S. Uhry, F. De Poli, P. Couppie, I.V. Simon, Olivier Morel, Philippe Ohlmann, H. Heyer, P. Leddet
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 70:299-307
RESUME But de l’etude Le catheterisme coronaire apres implantation d'une valve aortique par voie percutanee (TAVI) peut poser certaines difficultes, variables suivant le type de valve. L'objectif principal de notre etude est d’evaluer le taux de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fa131c4c6c6a6da931d37a74330be82
https://doi.org/10.1016/j.ancard.2021.08.008
https://doi.org/10.1016/j.ancard.2021.08.008
Autor:
Philippe Ohlmann, D P Truong, Benjamin Marchandot, J. Heger, Kensuke Matsushita, Laurence Jesel, Marion Kibler, Sébastien Hess, L Sattler, Antonin Trimaille, Olivier Morel, Chisato Sato, Antje Reydel, Lelia Grunebaum
Publikováno v:
European Heart Journal. 42
Introduction Patients with atrial fibrillation (AF) are likely to have multiple co-morbidities and receive anticoagulants after TAVR, which lead to a poor prognosis including bleeding events. Closure time adenosine diphosphate (CT-ADP) is a primary h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9303282c5e82a51d0e263f9cbdb5fc7b
https://doi.org/10.1093/eurheartj/ehab724.1631
https://doi.org/10.1093/eurheartj/ehab724.1631
Autor:
Cyril Auger, C Bruckert, Chisato Sato, W Fakih, Olivier Morel, Kensuke Matsushita, Gilles Kauffenstein, Laurence Jesel, Philippe Ohlmann, Valérie B. Schini-Kerth, L. Remila, D S Gong, S Hmadeh
Publikováno v:
European Heart Journal. 42
Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to reduce the risk of cardiovascular events independently of glycemic control. The possibility that SGLT2 inhibitors improve endothelial regeneration and vascular resteno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6500ffa1829232069f31c31c9d2df10f
https://doi.org/10.1093/eurheartj/ehab724.3409
https://doi.org/10.1093/eurheartj/ehab724.3409
Autor:
Kensuke Matsushita, Jean-Philippe Mazzucotelli, Sin-Hee Park, S Amissi, Valérie B. Schini-Kerth, E. Belcastro, A Mroueh, Laurence Jesel, Olivier Morel, P Algara-Suarez, C Bruckert, Philippe Ohlmann, D S Gong, A B Chaker
Publikováno v:
European Heart Journal. 42
Background Selective sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown cardiovascular protection independently of glycemic control. Angiotensin II (Ang II) and H2O2 induced the expression of SGLT1 and 2 in cultured endothelial cells and is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e979a9e2df5bede2067b93aa99bf641
https://doi.org/10.1093/eurheartj/ehab724.3440
https://doi.org/10.1093/eurheartj/ehab724.3440
Autor:
Valérie B. Schini-Kerth, Antonin Trimaille, J. Heger, K. Matsushita, Marion Kibler, Laurence Jesel, Philippe Ohlmann, A. Elidrissi, Olivier Morel, Benjamin Marchandot, Adrien Carmona, Samira Fafi-Kremer, Anais Curtiaud, Antje Reydel, Sébastien Hess, T. Cardi
Publikováno v:
Archives of Cardiovascular Diseases Supplements
Archives of Cardiovascular Diseases. Supplements
Archives of Cardiovascular Diseases. Supplements
Background Coronary artery disease (CAD) has been recognized as a major determinant of Covid-19 vulnerability and severity. We sought to compare demographic characteristics, clinical presentation, and outcomes for Covid-19 in a large cohort of chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc0fa94709d0d68af1f893bf757c1d1c
Autor:
Laurence Jesel, S. Greciano, Antonin Trimaille, Chisato Sato, P. Leddet, Antje Reydel, J. Heger, Kensuke Matsushita, C. Dagrenat, Benjamin Marchandot, Annie Trinh, Lucie Lachmet-Thébaud, Philippe Ohlmann, F De Poli, Olivier Morel
Publikováno v:
European Heart Journal. 41
Introduction Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with takotsubo cardiomyopathy, recent studies have demonstrated the long-lasting functional impairment in those patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2dd0253d259c78835244b84b85b7c69
https://doi.org/10.1093/ehjci/ehaa946.1184
https://doi.org/10.1093/ehjci/ehaa946.1184
Autor:
A B Chaker, P Algara-Suarez, Valérie B. Schini-Kerth, Cyril Auger, U. Houngue, L. Remila, Sin-Hee Park, C Bruckert, Kensuke Matsushita, Laurence Jesel, E. Belcastro, Olivier Morel, Philippe Ohlmann
Publikováno v:
European Heart Journal. 41
Background Selective sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown cardiovascular protection in type 2 diabetes patients with established cardiovascular disease independently of glycemic control. Angiotensin II (Ang II) and H2O2 have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55c923aa7c720e03c37169fc2e6fd9ee
https://doi.org/10.1093/ehjci/ehaa946.3806
https://doi.org/10.1093/ehjci/ehaa946.3806
Autor:
Antje Reydel, Chisato Sato, Mickaël Ohana, J. Heger, Benjamin Marchandot, Laurence Jesel, Antonin Trimaille, Marion Kibler, Lelia Grunebaum, Olivier Morel, Kensuke Matsushita, Marilou Peillex, Philippe Ohlmann, Sébastien Hess
Publikováno v:
European Heart Journal. 41
Introduction Current recommendations support short-term dual antiplatelet therapy (DAPT) for patients undergoing transcatheter aortic valve replacement (TAVR) despite no relevant study exploring the extent of platelet inhibition by clopidogrel. Purpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e9a70eb1183f0d07f4d3cac273df085
https://doi.org/10.1093/ehjci/ehaa946.1921
https://doi.org/10.1093/ehjci/ehaa946.1921
Autor:
Antonin Trimaille, Antje Reydel, Marilou Peillex, Kensuke Matsushita, J. Heger, Lelia Grunebaum, Philippe Ohlmann, Chisato Sato, Benjamin Marchandot, Mickaël Ohana, Olivier Morel, Marion Kibler, Laurence Jesel, Sébastien Hess
Publikováno v:
European Heart Journal. 41
Introduction Paravalvular leakage (PVL) following transcatheter aortic valve replacement (TAVR) is associated with greater mortality. In clinical practice, determining PVL severity after TAVR remains challenging and often requires multiparametric ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece6a124b9662bb4d0c4fc3656a60e21
https://doi.org/10.1093/ehjci/ehaa946.2581
https://doi.org/10.1093/ehjci/ehaa946.2581
Autor:
Adrien Carmona, Benjamin Marchandot, Chisato Sato, S. Greciano, F De Poli, Philippe Ohlmann, C. Dagrenat, Antje Reydel, Olivier Morel, Kensuke Matsushita, Sébastien Hess, Laurence Jesel, Marilou Peillex, Lucie Lachmet-Thébaud, P. Leddet
Publikováno v:
European Heart Journal. 41
Background Recent insights have emphasized the importance of myocardial and systemic inflammation in Takotsubo Syndrome (TTS). Objective In a large registry of unselected patients, we sought to evaluate whether residual high inflammatory response (RH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4828ab9b60d66fd6ceb938f784cc1a58
https://doi.org/10.1093/ehjci/ehaa946.1835
https://doi.org/10.1093/ehjci/ehaa946.1835